Objective-Inflammation and dysregulated angiogenesis are features of endothelial dysfunction in pulmonary hypertension.
A new type of neutrophil cell death called NETosis, first identified by Zychlinsky et al, 1 has been linked with the pathogenesis of numerous diseases, including atherosclerosis, 2 preeclampsia, 3 acute lung injury, 4 deep vein thrombosis, 5 and cancer-associated thrombosis. 6 During NETosis, neutrophil extracellular traps (NETs) are formed as a result of reactive oxygen species-triggered decondensation of chromatin dependent on histone hypercitrullination catalyzed by peptidylarginine deiminase 4 (PAD4). 7 The cells die releasing a net of chromatin fibers studded with neutrophil secretory granules containing neutrophil elastase and myeloperoxidase.
See accompanying editorial on page 2035
Neutrophils constitute the first line of defense in killing pathogens but are also necessary for tissue repair and the proper development and maintenance of healthy vasculature. 7 Neutrophils have been implicated in vascular inflammatory processes in pulmonary hypertension, a condition characterized by progressive thickening of small intrapulmonary arteries because of increased endothelial and smooth muscle proliferation, endothelial dysfunction and in situ thrombosis. 8, 9 Factors implicated in the pathogenesis of PH such as oxidative stress, interleukin-8 (IL-8), tumor necrosis factor-α or ribonucleoprotein immune complexes can induce NET formation in vitro, 1, [10] [11] [12] but the potential link between the pathophysiology of pulmonary hypertension and NETosis has not been investigated.
The clinical classification of PH categorizes the disease into 5 groups, with pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTEPH) being most common. 9, 13 PAH may occur either as a primary disease of unknown cause (idiopathic PAH [IPAH]), as a result of loss-of-function mutations in the transforming growth factor β/bone morphogenetic protein receptor superfamily (heritable PAH), or as an associated manifestation of other diseases. 9 A hallmark of severe PAH is the presence of plexiform lesions, complex vascular formations characterized by disorganized angiogenesis, inflammation, and thrombosis. 14 CTEPH is caused by chronic obstruction of major pulmonary arteries by nonresolving thrombi and a concomitant small-vessel arteriopathy. 15 Endarterectomized tissues from patients with CTEPH show vessel-like structures in material obtained from distal areas, whereas proximal material is characterized by lower cell density and sometimes the accumulation of fresh thrombotic material. 16 In this study, we aimed to establish whether NET formation is a feature of vascular pathology in CTEPH and PAH, study the effects of NETs on pulmonary endothelial and smooth muscle responses in vitro, and investigate the signaling mechanisms involved. We are the first to document NET formation in CTEPH and PAH and show that NETs trigger inflammatory activation of pulmonary endothelial cells and promote endothelial angiogenesis in vitro and in vivo via myeloperoxidase/ H 2 O 2 /nuclear factor κB (NFκB)/TLR4-dependent signaling.
Methods
An expanded Materials and Methods section is available in the online-only Data Supplement.
Results

Markers of NETosis Are Increased in Plasma and Lung Tissues From PAH and CTEPH Patients
NET formation (NETosis) is commonly identified by elevated levels of 2 or more markers of NETs, such as circulating DNA, myeloperoxidase, neutrophil elastase, or citrullinated histone 3. CTEPH (n=26) and IPAH (n=52) patients showed increased plasma levels of myeloperoxidase (10-fold increase in CTEPH and 5.6-fold increase in IPAH), neutrophil elastase (7-fold increase in CTEPH and 5.3-fold increase in IPAH), and circulating DNA (1.5-fold increase in CTEPH and 1.5fold increase in IPAH), compared with plasma from age-and sex-matched healthy volunteers (n=24; Figure 1A through 1C). Elevated levels of NET markers were also found in the independent external cohort of patients with CTEPH from Papworth Hospital (n=21; Figure I in the online-only Data Supplement). As circulating free DNA may come from various cellular sources, 17 the analysis of DNA-myeloperoxidase complexes may provide a more accurate measurement of NET levels in plasma. 18 Consistently, both IPAH and CTEPH patient cohorts showed significantly elevated plasma levels of DNA-myeloperoxidase complexes ( Figure 1D ). Patient characteristics are shown in Table I in the online-only Data Supplement. No correlation between the marker levels and other variables, such as age or drug treatment, was observed (data not shown).
Histological analysis of lung tissues from patients with IPAH showed areas of NETosis marked by colocalization of DNA, myeloperoxidase, and citrullinated histone H3, particularly evident in the occlusive plexiform lesions ( Figure 1E ). IPAH lung tissues also showed increased accumulation of NET-forming, PAD4 + neutrophils along the vascular wall and around the remodeled vessels, whereas control tissues showed no staining ( Figure 1E ). IPAH lung tissues also displayed a marked staining of endothelial L-endoglin, a known regulator of tumor-related angiogenesis and neovascularization 19 ( Figure IIA in the online-only Data Supplement). Endarterectomy specimens from patients with CTEPH showed a marked colocalization of DNA, myeloperoxidase, and citrullinated histone 3 and the presence of NET-forming PAD4 + neutrophils ( Figure 1F ; Figure 
NETs Promote Proinflammatory and Prothrombotic Responses in Human Pulmonary Artery Endothelial Cells
Endothelial dysfunction is a key contributor to vascular remodeling in PH, and we investigated the effects of NETs on cultured human pulmonary artery endothelial cells (HPAECs). NETs appeared as large, mesh-like structures showing colocalization of DNA with citrullinated histone H3 and myeloperoxidase ( Figure III in the online-only Data Supplement); 2×10 6 neutrophils provided ≈2.8 µg of NET DNA.
NETs induced ≈3-fold increase in the activity of the proinflammatory transcription factor, NFκB in HPAECs ( Figure 2A ). Fragmentation of NETs with DNase1 prevented this response, reinforcing the importance of structural integrity of NETs. To determine whether a direct contact of NETs with the endothelial surface was required, HPAECs were separated from NETs by a porous (0.4-µm pore size) membrane in Transwell dishes ( Figure Figure 2B ).
Myeloperoxidase/H 2 O 2 signaling drives inflammatory reactions and tissue oxidation and promotes nuclear translocation and activation of NFκB in cells. 20, 21 In HPAECs, NFκB activation was prevented by myeloperoxidase inhibitor I and catalase, arguing for the major role of myeloperoxidaseinduced reactive oxygen species generation in NETs-induced inflammatory signaling. NETs also markedly augmented the NFκB-dependent expression of intercellular adhesion molecule-1 (ICAM-1) in HPAECs, an important mediator of leukocyte adhesion and transmigration ( Figure 2C ). Consistent with their prothrombotic effects, 22 NETs induced ≈5-fold increase in the surface expression and 1.2-fold increase in total protein expression of von Willebrandt Factor ( Figure  V 
NETs Increase Endothelial Angiogenesis In Vitro
The presence of NETs in plexiform lesions and vascularized CTEPH thrombi focused our interest on the potential role of NETs in the regulation of angiogenesis. The effect of NETs on endothelial angiogenesis was studied in a 2-dimensional matrigel tube formation assay, reflecting intusussceptive angiogenesis and in a 3-dimensional spheroid sprouting assay, informing the effect of NETs on sprouting angiogenesis. NETs (24 hours) significantly increased capillary tube length and network maturity, measured as several completed Human angiogenesis microarray analysis of NETs-treated HPAECs revealed a significantly increased expression levels of several proangiogenic factors, including matrix metalloproteinase-9 (MMP-9), platelet-derived growth factor AB/BB (PDGF-AB/PDGF-BB), heparin-binding epidermal growth factor (EGF)-like growth factor, latency-associated peptide of the transforming growth factor β1, and urokinase-type plasminogen activator, compared with untreated controls (Figures VI and VII in the online-only Data Supplement). Microarray analysis of NET components alone revealed only traces of MMP-9 and latency-associated peptide of the transforming growth factor β1 but did not show any other proangiogenic factors found elevated in HPAECs ( Figure VI in the online-only Data Supplement). To further explain the mechanism of the proangiogenic effects of NETs, we recorded endothelial cell movement and used chemotaxis and migration analysis software to provide images of cell trajectories and compare parameters of cell movement in the untreated and NETstreated HPAECs. NETs increased the total length of cell trajectories (accumulated distance), cell translocation (distance in a straight line between the start and the end point of each trajectory), and increased the speed of cell movement ( Figure 4C through 4G), without affecting directionality (data not shown). In agreement with the results obtained in angiogenesis assays, NETs-induced increase in the endothelial cell migration was attenuated in the presence of DNase1 and myeloperoxidase inhibitor I ( Figure IX in the online-only Data Supplement).
NETs Increase Proliferative Activity of HPAECS, Destabilize Intercellular Endothelial Junctions, and Increase Endothelial Cell Motility
Conditioned media from NETs-treated HPAECs contain increased levels of endothelin-1 (ET-1) and increased proliferation of human pulmonary artery smooth muscle cells in vitro.
Vasoactive agents released by the activated endothelium, such as PDGF or ET-1, are known stimulators of vascular cell migration and proliferation and may potentially contribute to the vascular remodeling in disease conditions. We measured ET-1 levels in conditioned media from NETs-treated HPAECs and noted a significant increase in ET-1 (≈2.3-fold increase) secreted by these cells ( Figure XA in the online-only Data Supplement). Incubation of human pulmonary artery smooth muscle cells with conditioned media from NETs-treated HPAECs significantly enhanced PASMC proliferation in vitro ( Figure XB in the online-only Data Supplement). Interestingly, preliminary analysis of CTEPH plasma (Papworth Hospital cohort; n=21) revealed a significant correlation between the levels of ET-1 and the levels of DNA, myeloperoxidase, and neutrophil elastase (Table) .
Toll-Like Receptor 4 Mediates the Proinflammatory and Proangiogenic Effects of NETs
Activation of Toll-like receptor 4 (TLR4) by oxidative stress has been implicated in the pathogenesis of PH and was shown to induce inflammatory angiogenesis and increased expression of ICAM-1 and ET-1 in endothelial cells, 23,24 reminiscent of the phenotype induced by NETs. We, therefore, hypothesized that TLR4 may act as a mediator of NETs-induced effects reported in this study.
Incubation of cells with TLR4 inhibitor prevented NETsinduced NFκB activation, tube formation, and spheroid sprouting ( Figure 5A through 5C ). Western blotting analysis revealed a transient activation of TLR4 signaling, manifested by increased phosphorylation of TLR4 effector, IRAK4, whereas total expression levels of IRAK4 and TLR4 remained unchanged ( Figure 5D through 5H) .
Our recent studies documented a key role of redox-sensitive CLIC4 (chloride intracellular protein 4) in the regulation of NFκB activation and hypoxia-inducible factor-driven angiogenesis. 25 Interestingly, activation of TLR4 by NETs was accompanied by increased expression of CLIC4 in HPAECs, consistent with the proinflammatory and proangiogenic phenotype (Figure 5F ).
NETs-induced spheroid sprouting was inhibited by CLIC4shRNA, confirming the importance of this protein in the regulation of endothelial angiogenic responses ( Figure XI in the online-only Data Supplement).
NETs Increase Angiogenesis In Vivo
To investigate the effect of NETs on angiogenesis in vivo, matrigel containing equal amounts of either mouse or human NET DNA was injected subcutaneously into mice. Although mouse and human NETs were similar in appearance, human NETs tended to cluster to form larger aggregates ( Figure XII in the online-only Data Supplement).
Both mouse and human NETs significantly increased plug vascularization, with human NETs having a more pronounced effect (2-fold increase compared with controls, P<0.05; Figure 6 ). Hematoxylin and eosin and DNA staining revealed increased cellularity of plugs containing mouse and human NETs, compared with controls ( Figure 6 ).
Discussion
This report is the first to implicate NETs in angiogenesis and in diseases characterized by disordered vascular homoestasis in the pulmonary vasculature. We demonstrate their role in the regulation of proinflammatory, proangiogenic responses in human endothelial cells via the activation of myeloperoxidase/H 2 O 2 -mediated TLR signaling. Proangiogenic effects of NETs were confirmed in 3 different models of angiogenesis, in the matrigel tube formation and spheroid sprouting assays in vitro and in the matrigel plug formation assay in vivo. Angiogenesis is a complex process in which endothelial cells migrate, proliferate, and invade the surrounding tissues to form capillaries. Subsequent migration and proliferation of pericytes, fibroblasts, and smooth muscle cells contributes to vessel maturation. Our study has revealed a complex pattern of responses in NETs-stimulated HPAECs, involving increased endothelial proliferative/metabolic activity, increased motility, and increased endothelial permeability in vitro. These effects are likely to result from the actions of numerous vasoactive agents released by NETs-treated HPAECs, including MMP-9 and urokinase-type plasminogen activator, known to liberate proangiogenic growth factors sequestered to the extracellular matrix 26 and stimulators of cell migration and proliferation, such as latency-associated peptide of the transforming growth factor β1, heparin-binding EGF-like growth factor, and PDGF. In addition to the observations reported in this study, NETs were also shown to increase Correlation coefficients of all markers from the combined data are shown and those that were significant and highly correlated are marked with an asterisk (P≤0.05, Spearman correlation). CTEPH indicates chronic thromboembolic pulmonary hypertension; ET-1, endothelin-1; MPO, myeloperoxidase; and NE, neutrophil elastase. cytokine/growth factor release in macrophages. 2 Incubation of HPAECs with NETs significantly increased the expression of ICAM-1 in HPAECs, consistent with other reports. 5, 27 ICAM-1 is an important regulator of angiogenesis 28 and can support VEGF (vascular endothelial growth factor)-induced endothelial cell migration and facilitate recruitment of endothelial progenitor cells. 29 Another factor released by HPAECs, heparin-binding EGF-like growth factor, is mitogenic and chemotactic for vascular smooth muscle cells, keratinocytes, fibroblasts, and cardiomyocytes. 30, 31 Together with PDGF-BB, HB-FGF promotes new vessel formation by recruiting mesenchymal cells during the late phase of angiogenesis.
Table. Correlation Matrix of NET Markers With ET-1 in Plasma of Patients With CTEPH (Cambridge Cohort, n=21)
Activated neutrophils are a source of MMP9 and VEGF 32 ; and therefore, we considered a possibility that some of the proangiogenic factors found in HPAEC lysates may have originated from neutrophil cell/NET fragments internalized by the endothelial cells. However, apart from the traces of MMP9 and latency-associated peptide 1, NET preparations did not contain any of the factors found elevated in NETs-treated HPAECs, consistent with the analyses carried out by others. 33 Experiments performed in our and other laboratories indicate that NETs can induce a spectrum of activities in cells, depending on the amount of NET material added to the endothelial cell culture. The amount of NETs produced by ≈2 to 3 NETforming neutrophils per 10 endothelial cells (0.3-µg/mL NETs DNA) evokes proinflammatory and proangiogenic responses in endothelial cells. However, 10-to 30-fold higher concentrations of NETs enhance endothelial apoptosis, likely to reflect conditions in severe sepsis. 34 Our observations also emphasize the importance of a localized, direct contact of NET fibers with the endothelial cell surface.
The proinflammatory and proangiogenic effects of NETs depended on the myeloperoxidase/H 2 O 2 signaling, resembling the actions of activated neutrophils. 35 H 2 O 2 increases the expression of MMPs 1, 3, and 9 and urokinase-type plasminogen activator in endothelial cells 35 and activates several kinases associated with increased cell proliferation and migration, including Akt, p38 MAPK, and ERK1/2. 36 We focused our attention on TLR4 as a likely mediator of myeloperoxidase/H 2 O 2 -induced responses. Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation, 37 which activates TLR4 in endothelial cells. 38 Activated TLR4 can trigger NFκB activity, ICAM-1 expression, and ET-1 release, 23 consistent with the phenotype seen in NETsstimulated HPAECs. In further support of the role of TLR4, TLR4 inhibitors completely prevented NETs-induced NFκB activation and endothelial angiogenesis. NETs induced a rapid (30 minutes-1 hour) activation of TLR4 signaling in NETstreated HPAECs, corresponding to the timecourse of receptor activation induced by peroxidized lipids. 38 Interestingly, in addition to the TLR4 activation, we noted a cotemporary increase in the expression of CLIC4. CLIC4 is activated by reactive oxygen species, and its expression is increased in the endothelium of remodeled vessels and plexiform lesions in human PAH and animal models of PAH. 25 CLIC4 gene silencing completely inhibited NET-induced spheroid sprouting, reinforcing the key role of this protein in the regulation of endothelial angiogenesis. The link between CLIC4 and TLR4 signaling will require further studies, but CLIC4 was shown to increase phosphorylation of p65 subunit of NFκB, important for the NFκB-induced hypoxia-inducible factor activation and pulmonary endothelial angiogenesis in vitro. 25 Having demonstrated that NETs increase pulmonary endothelial cell motility and angiogenic responses in vitro, we then investigated the angiogenic effects of NETs in vivo.
Apart from endothelial cells, the mechanism of NETs-induced angiogenesis in vivo is likely to involve other cell types. For instance, NETs provide a scaffold for thrombus formation by capturing erythrocytes and platelets 39 and platelet-derived thrombin is known to enhance the secretion of VEGF and MMP-9 and synergize with VEGF in stimulating endothelial cell proliferation. 40 Our results provide arguments for a potential role of NETs-induced signaling in the vascular pathology of CTEPH and PAH. Immunohistochemical staining of lung sections revealed a marked accumulation of NET-forming PAD4 + leukocytes and NET markers at the vascular wall and in the perivascular space of the occlusive plexiform lesions from patients with IPAH. These changes were cocurrent with increased expression of L-endoglin, typically found in proliferating endothelial cells during neovessel formation. 41 The mechanisms leading to complex vascular formations in PAH are not well understood but numerous studies have documented the presence of continuously proliferating endothelial cells and sprouting vascular channels, accompanied by increased expression of MMP-9 and other mediators of angiogenesis. 14 PAD4 + neutrophils and NET markers were also identified in the intrapulmonary thrombi from patients with CTEPH. It is conceivable that NETs may facilitate local pulmonary vascular remodeling by increasing vascular cell proliferation and migration. Consistent with this, we observed increased proliferative activity of PASMCs induced by conditioned media from NETs-treated HPAECs and increased levels of ET-1, a potent mitogen for vascular endothelial and smooth muscle cells 42 and a vasoconstrictor implicated in the pathogenesis of PH. 9 NET markers significantly correlated with ET-1 levels in plasma of patients with CTEPH, suggesting that ET-1 may, in addition to the other identified mediators, play a regulatory role in NET-induced responses.
Deficiency of bone morphogenetic protein receptor II signaling in PAH may further augment NET formation/signaling by facilitating neutrophil migration to the diseased lung and provide a positive regulatory feedback loop by TLR4dependent increase in IL-8, a cytokine known to induce NET formation in vitro. 43, 44 Future studies should also address the role of NETs in the pathogenesis of PH and investigate whether neutrophils from PAH and CTEPH patients show increased propensity to form NETs. This would not be entirely unexpected because PAH and CTEPH neutrophils respond to stimulation with increased inflammatory mediator generation ex vivo, including increased respiratory burst, elastase secretion, and lipid mediator synthesis. 45 It is important to note that IPAH plexiform lesions form predominantly in the precapillary vessels consisting of endothelial microvascular cells, which may differ in their responses from macrovascular cells used in this study. Another potential avenue for future studies may include a functional link between NET formation and angiogenesis in other conditions characterized by abnormal vascularization, inflammation, and elevated NET markers in plasma and diseased organs/tissues, such as rheumatoid arthritis, cancer, and connective tissue diseases. 6, 46, 47 To summarize, we are the first to document that NETs are proangiogenic and demonstrate a potential contributory role of NETs in the vascular pathology of human CTEPH and PAH, characterized by the activation of local proinflammatory and proangiogenic responses in pulmonary vascular endothelium via reactive oxygen species-induced TLR4-mediated signaling.
